SEC Form 4 · accession 0001144204-18-019985
ANI PHARMACEUTICALS INC · ANIP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert W Schrepfer
Officer — SVP - New Bus Dev & Spec Sales
Period of report
Apr 6, 2018
Accepted (ET)
Apr 10, 2018 · 5:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001023024
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 6, 2018 | A | 8,000 | $0.00 | A | 20,392 | D | |
| Common Stock | Apr 7, 2018 | F | 391 | $57.06 | D | 20,001 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $57.06 | Apr 6, 2018 | A | 9,600 | A | — | Apr 5, 2028 | Common Stock | 9,600 | 9,600 | D |
Explanation of responses
- F1The restricted stock and the stock options vests, and are exercisable, in equal annual installments on the first, second, third and fourth anniversaries of the grant date.
- F2Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of restricted stock, which was previously reported.